Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 66, Issue 21, pp. 2329 - 2338
Background Evidence from large, randomized, controlled peripheral artery disease trials reporting long-term outcomes using drug-coated balloons (DCBs) is...
peripheral arterial disease | target lesion revascularization | femoropopliteal artery | target lesion revascularization | angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | PACLITAXEL-ELUTING STENTS | FOLLOW-UP | NITINOL STENT IMPLANTATION | INHIBITION | CLINICAL IMPACT | SUPERFICIAL FEMORAL-ARTERY | DISEASE | RESTENOSIS | LIFE | Angioplasty - standards | Angioplasty - trends | Single-Blind Method | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Popliteal Artery - diagnostic imaging | Femoral Artery - diagnostic imaging | Angioplasty, Balloon - standards | Time Factors | Internationality | Ultrasonography | Female | Aged | Paclitaxel - administration & dosage | Angioplasty, Balloon - trends
peripheral arterial disease | target lesion revascularization | femoropopliteal artery | target lesion revascularization | angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | PACLITAXEL-ELUTING STENTS | FOLLOW-UP | NITINOL STENT IMPLANTATION | INHIBITION | CLINICAL IMPACT | SUPERFICIAL FEMORAL-ARTERY | DISEASE | RESTENOSIS | LIFE | Angioplasty - standards | Angioplasty - trends | Single-Blind Method | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Popliteal Artery - diagnostic imaging | Femoral Artery - diagnostic imaging | Angioplasty, Balloon - standards | Time Factors | Internationality | Ultrasonography | Female | Aged | Paclitaxel - administration & dosage | Angioplasty, Balloon - trends
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 06/2010, Volume 3, Issue 3, pp. 267 - 276
BACKGROUND—Controversy still exists regarding the best endovascular treatment strategy for patients with symptomatic disease of the superficial femoral artery....
Peripheral vascular disease | Angioplasty | Stents | FRACTURE | CARDIAC & CARDIOVASCULAR SYSTEMS | PLACEMENT | stents | OBSTRUCTIONS | TRANSLUMINAL ANGIOPLASTY | DISEASE | FEMOROPOPLITEAL ARTERY | PTA | peripheral vascular disease | angioplasty | Femoral Artery - pathology | Angiography | Follow-Up Studies | United States | Humans | Middle Aged | Male | Popliteal Artery - drug effects | Arterial Occlusive Diseases - pathology | Female | Popliteal Artery - surgery | Angioplasty, Balloon | Arterial Occlusive Diseases - physiopathology | Ultrasonography, Doppler, Duplex | Alloys - administration & dosage | Prosthesis Implantation | Europe | Arterial Occlusive Diseases - diagnostic imaging | Treatment Outcome | Femoral Artery - drug effects | Popliteal Artery - diagnostic imaging | Femoral Artery - diagnostic imaging | Aged | Popliteal Artery - pathology | Drug-Eluting Stents - utilization | Femoral Artery - surgery | Alloys - adverse effects | Arterial Occlusive Diseases - therapy
Peripheral vascular disease | Angioplasty | Stents | FRACTURE | CARDIAC & CARDIOVASCULAR SYSTEMS | PLACEMENT | stents | OBSTRUCTIONS | TRANSLUMINAL ANGIOPLASTY | DISEASE | FEMOROPOPLITEAL ARTERY | PTA | peripheral vascular disease | angioplasty | Femoral Artery - pathology | Angiography | Follow-Up Studies | United States | Humans | Middle Aged | Male | Popliteal Artery - drug effects | Arterial Occlusive Diseases - pathology | Female | Popliteal Artery - surgery | Angioplasty, Balloon | Arterial Occlusive Diseases - physiopathology | Ultrasonography, Doppler, Duplex | Alloys - administration & dosage | Prosthesis Implantation | Europe | Arterial Occlusive Diseases - diagnostic imaging | Treatment Outcome | Femoral Artery - drug effects | Popliteal Artery - diagnostic imaging | Femoral Artery - diagnostic imaging | Aged | Popliteal Artery - pathology | Drug-Eluting Stents - utilization | Femoral Artery - surgery | Alloys - adverse effects | Arterial Occlusive Diseases - therapy
Journal Article
European Journal of Vascular & Endovascular Surgery, ISSN 1078-5884, 2012, Volume 44, Issue 4, pp. 432 - 441
Abstract Objective The study aims to evaluate the safety and the efficacy of primary stenting for Trans-Atlantic Inter-Society Consensus Document II on...
Surgery | Peripheral artery disease | Femoropopliteal | TASC C and D | Angioplasty | Stent | Critical ischaemia | SURGERY | TRIALS | CORONARY | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | NITINOL STENT | FRACTURE | IMPLANTATION | SUBINTIMAL ANGIOPLASTY | ARTERY LESIONS | PERIPHERAL VASCULAR DISEASE | Prospective Studies | Angiography | Follow-Up Studies | Humans | Arterial Occlusive Diseases - diagnostic imaging | Male | Treatment Outcome | Blood Vessel Prosthesis | Prosthesis Design | Consensus Development Conferences as Topic | Endovascular Procedures - methods | Societies, Medical | Leg - blood supply | Arterial Occlusive Diseases - surgery | Female | Aged | Popliteal Artery - pathology | France | Femoral Artery - surgery | Stents | Stent (Surgery)
Surgery | Peripheral artery disease | Femoropopliteal | TASC C and D | Angioplasty | Stent | Critical ischaemia | SURGERY | TRIALS | CORONARY | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | NITINOL STENT | FRACTURE | IMPLANTATION | SUBINTIMAL ANGIOPLASTY | ARTERY LESIONS | PERIPHERAL VASCULAR DISEASE | Prospective Studies | Angiography | Follow-Up Studies | Humans | Arterial Occlusive Diseases - diagnostic imaging | Male | Treatment Outcome | Blood Vessel Prosthesis | Prosthesis Design | Consensus Development Conferences as Topic | Endovascular Procedures - methods | Societies, Medical | Leg - blood supply | Arterial Occlusive Diseases - surgery | Female | Aged | Popliteal Artery - pathology | France | Femoral Artery - surgery | Stents | Stent (Surgery)
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2013, Volume 58, Issue 1, pp. 73 - 83.e1
Objective Angioplasty and stenting are options for revascularization of symptomatic femoral popliteal disease. Although angioplasty alone is effective in short...
Surgery | SURGERY | ELUTING STENTS | PLACEMENT | IMPLANTATION | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | FEMOROPOPLITEAL | OBSTRUCTIONS | DISEASE | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | PTA | Predictive Value of Tests | Prospective Studies | Constriction, Pathologic | United States | Ankle Brachial Index | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Exercise Test | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Adult | Female | Ultrasonography, Doppler, Duplex | Stents | Europe | Femoral Artery - physiopathology | Alloys | Kaplan-Meier Estimate | Treatment Outcome | Chi-Square Distribution | Popliteal Artery - diagnostic imaging | Angioplasty, Balloon - instrumentation | Peripheral Arterial Disease - therapy | Disease-Free Survival | Peripheral Arterial Disease - physiopathology | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnosis | Exercise Tolerance | Aged | Vascular Patency | Consulting services | Stent (Surgery) | Nickel alloys
Surgery | SURGERY | ELUTING STENTS | PLACEMENT | IMPLANTATION | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | FEMOROPOPLITEAL | OBSTRUCTIONS | DISEASE | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | PTA | Predictive Value of Tests | Prospective Studies | Constriction, Pathologic | United States | Ankle Brachial Index | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Exercise Test | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Adult | Female | Ultrasonography, Doppler, Duplex | Stents | Europe | Femoral Artery - physiopathology | Alloys | Kaplan-Meier Estimate | Treatment Outcome | Chi-Square Distribution | Popliteal Artery - diagnostic imaging | Angioplasty, Balloon - instrumentation | Peripheral Arterial Disease - therapy | Disease-Free Survival | Peripheral Arterial Disease - physiopathology | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnosis | Exercise Tolerance | Aged | Vascular Patency | Consulting services | Stent (Surgery) | Nickel alloys
Journal Article
Journal of Endovascular Therapy, ISSN 1526-6028, 2/2015, Volume 22, Issue 1, pp. 14 - 21
Purpose: To evaluate the safety and efficacy of the novel Passeo-18 Lux paclitaxel-coated balloon compared with the Passeo-18 uncoated balloon in patients with...
Balloon angioplasty | Occlusion | Superficial femoral artery | Drug-eluting balloon | Peripheral artery disease | Stenosis | Drugcoated balloon | Popliteal artery | Paclitaxel-coated balloon | Restenosis | BTHC | Femoropopliteal lesions | Drug-releasing balloon | SURGERY | restenosis | peripheral artery disease | drug-eluting balloon | STENTS | drug-coated balloon | balloon angioplasty | stenosis | popliteal artery | COATED BALLOONS | femoropopliteal lesions | ANGIOPLASTY | paclitaxel-coated balloon | occlusion | drug-releasing balloon | superficial femoral artery | PERIPHERAL VASCULAR DISEASE | ELUTING BALLOON | ARTERY-DISEASE | Cardiovascular Agents - administration & dosage | Limb Salvage | Prospective Studies | Follow-Up Studies | Ankle Brachial Index | Humans | Middle Aged | Male | Treatment Outcome | Coated Materials, Biocompatible | Excipients - administration & dosage | Popliteal Artery - diagnostic imaging | Peripheral Arterial Disease - therapy | Radiography | Austria | Femoral Artery - diagnostic imaging | Aged, 80 and over | Peripheral Arterial Disease - diagnostic imaging | Butyrates - administration & dosage | Female | Aged | Angioplasty, Balloon | Paclitaxel - administration & dosage | Germany
Balloon angioplasty | Occlusion | Superficial femoral artery | Drug-eluting balloon | Peripheral artery disease | Stenosis | Drugcoated balloon | Popliteal artery | Paclitaxel-coated balloon | Restenosis | BTHC | Femoropopliteal lesions | Drug-releasing balloon | SURGERY | restenosis | peripheral artery disease | drug-eluting balloon | STENTS | drug-coated balloon | balloon angioplasty | stenosis | popliteal artery | COATED BALLOONS | femoropopliteal lesions | ANGIOPLASTY | paclitaxel-coated balloon | occlusion | drug-releasing balloon | superficial femoral artery | PERIPHERAL VASCULAR DISEASE | ELUTING BALLOON | ARTERY-DISEASE | Cardiovascular Agents - administration & dosage | Limb Salvage | Prospective Studies | Follow-Up Studies | Ankle Brachial Index | Humans | Middle Aged | Male | Treatment Outcome | Coated Materials, Biocompatible | Excipients - administration & dosage | Popliteal Artery - diagnostic imaging | Peripheral Arterial Disease - therapy | Radiography | Austria | Femoral Artery - diagnostic imaging | Aged, 80 and over | Peripheral Arterial Disease - diagnostic imaging | Butyrates - administration & dosage | Female | Aged | Angioplasty, Balloon | Paclitaxel - administration & dosage | Germany
Journal Article
Journal of Cardiovascular Surgery, ISSN 0021-9509, 02/2013, Volume 54, Issue 1, pp. 115 - 122
Aim. The aim of the present article was to report the 12-month results of the Zilver (R) PTX (R) Single Arm StudyTASC C/D de novo lesion subgroup. Methods. The...
Peripheral arterial disease | Femoral artery | Drug-eluting stents | Paclitaxel | SURGERY | KNEE FEMOROPOPLITEAL BYPASS | CRITICAL LIMB ISCHEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | LOWER-EXTREMITY | IMPLANTATION | SUPERFICIAL FEMORAL-ARTERY | SUBINTIMAL ANGIOPLASTY | DISEASE | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | NITINOL STENTS | Drug-Eluting Stents | Paclitaxel - pharmacology | Peripheral Arterial Disease - surgery | Prospective Studies | Follow-Up Studies | Femoral Artery - physiopathology | Humans | Male | Treatment Outcome | Prosthesis Design | Peripheral Arterial Disease - physiopathology | Endovascular Procedures - methods | Time Factors | Popliteal Artery - physiopathology | Female | Popliteal Artery - surgery | Aged | Femoral Artery - surgery | Vascular Patency
Peripheral arterial disease | Femoral artery | Drug-eluting stents | Paclitaxel | SURGERY | KNEE FEMOROPOPLITEAL BYPASS | CRITICAL LIMB ISCHEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | LOWER-EXTREMITY | IMPLANTATION | SUPERFICIAL FEMORAL-ARTERY | SUBINTIMAL ANGIOPLASTY | DISEASE | BALLOON ANGIOPLASTY | PERIPHERAL VASCULAR DISEASE | NITINOL STENTS | Drug-Eluting Stents | Paclitaxel - pharmacology | Peripheral Arterial Disease - surgery | Prospective Studies | Follow-Up Studies | Femoral Artery - physiopathology | Humans | Male | Treatment Outcome | Prosthesis Design | Peripheral Arterial Disease - physiopathology | Endovascular Procedures - methods | Time Factors | Popliteal Artery - physiopathology | Female | Popliteal Artery - surgery | Aged | Femoral Artery - surgery | Vascular Patency
Journal Article
Circulation Journal, ISSN 1346-9843, 04/2011, Volume 75, Issue 4, pp. 939 - 944
Background: The use of a stent in the treatment of lesions of the superficial femoral artery (SFA) remains controversial. Although some reports have suggested...
Superficial femoral artery | S.M.A.R.T. Control™ stent | Endovascular therapy | CILOSTAZOL | CARDIAC & CARDIOVASCULAR SYSTEMS | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | OBSTRUCTIONS | SMART Control (TM) stent | IMPLANTATION | FEMOROPOPLITEAL | DISEASE | BALLOON ANGIOPLASTY | NITINOL STENTS | PATENCY | Age Factors | Follow-Up Studies | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Male | Cilostazol | Peripheral Arterial Disease - therapy | Graft Occlusion, Vascular - etiology | Time Factors | Tetrazoles - administration & dosage | Aged, 80 and over | Female | Femoral Artery | Registries | Aged | Tetrazoles - adverse effects | Vasodilator Agents - adverse effects | Stents | Vasodilator Agents - administration & dosage
Superficial femoral artery | S.M.A.R.T. Control™ stent | Endovascular therapy | CILOSTAZOL | CARDIAC & CARDIOVASCULAR SYSTEMS | PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY | OBSTRUCTIONS | SMART Control (TM) stent | IMPLANTATION | FEMOROPOPLITEAL | DISEASE | BALLOON ANGIOPLASTY | NITINOL STENTS | PATENCY | Age Factors | Follow-Up Studies | Humans | Middle Aged | Graft Occlusion, Vascular - prevention & control | Male | Cilostazol | Peripheral Arterial Disease - therapy | Graft Occlusion, Vascular - etiology | Time Factors | Tetrazoles - administration & dosage | Aged, 80 and over | Female | Femoral Artery | Registries | Aged | Tetrazoles - adverse effects | Vasodilator Agents - adverse effects | Stents | Vasodilator Agents - administration & dosage
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2015, Volume 66, Issue 21, pp. 2339 - 2342
femoropopliteal disease | peripheral artery disease | drug-coated balloons | CARDIAC & CARDIOVASCULAR SYSTEMS | COATED BALLOON ANGIOPLASTY | SUPERFICIAL FEMORAL-ARTERY | DISEASE | RANDOMIZED-TRIAL | Femoral Artery - diagnostic imaging | Humans | Ultrasonography | Female | Male | Paclitaxel - administration & dosage | Popliteal Artery - diagnostic imaging | Angioplasty, Balloon - trends
Journal Article
CardioVascular and Interventional Radiology, ISSN 0174-1551, 2/2015, Volume 38, Issue 1, pp. 25 - 32
The hypothesis that covered stents are superior to bare-metal stents (BMS) in long femoropopliteal artery disease was tested. The one-year results of the...
Stentgraft | Medicine & Public Health | Peripheral arterial disease | Femoropopliteal | Nuclear Medicine | Imaging / Radiology | Cardiology | Ultrasound | Stent | CRITICAL LIMB ISCHEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | BYPASS | FEMOROPOPLITEAL LESIONS | SINGLE-CENTER | GRAFT | TASC C | DISEASE | SUPERFICIAL-FEMORAL-ARTERY | BALLOON ANGIOPLASTY | NITINOL STENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Single-Blind Method | Drug-Eluting Stents | Prospective Studies | Ultrasonography, Doppler, Color | Anticoagulants - administration & dosage | Follow-Up Studies | Ankle Brachial Index | Humans | Heparin - administration & dosage | Male | Tomography, X-Ray Computed | Treatment Outcome | Popliteal Artery - diagnostic imaging | Equipment Design | Peripheral Arterial Disease - therapy | Femoral Artery - diagnostic imaging | Coated Materials, Biocompatible - therapeutic use | Female | Aged | Anticoagulants (Medicine) | Stent (Surgery) | Glycosaminoglycans | PATIENTS | ARTERIES | DISEASES | METALS | BIOMEDICAL RADIOGRAPHY | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | COMPARATIVE EVALUATIONS | HEPARIN
Stentgraft | Medicine & Public Health | Peripheral arterial disease | Femoropopliteal | Nuclear Medicine | Imaging / Radiology | Cardiology | Ultrasound | Stent | CRITICAL LIMB ISCHEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | BYPASS | FEMOROPOPLITEAL LESIONS | SINGLE-CENTER | GRAFT | TASC C | DISEASE | SUPERFICIAL-FEMORAL-ARTERY | BALLOON ANGIOPLASTY | NITINOL STENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Single-Blind Method | Drug-Eluting Stents | Prospective Studies | Ultrasonography, Doppler, Color | Anticoagulants - administration & dosage | Follow-Up Studies | Ankle Brachial Index | Humans | Heparin - administration & dosage | Male | Tomography, X-Ray Computed | Treatment Outcome | Popliteal Artery - diagnostic imaging | Equipment Design | Peripheral Arterial Disease - therapy | Femoral Artery - diagnostic imaging | Coated Materials, Biocompatible - therapeutic use | Female | Aged | Anticoagulants (Medicine) | Stent (Surgery) | Glycosaminoglycans | PATIENTS | ARTERIES | DISEASES | METALS | BIOMEDICAL RADIOGRAPHY | HYPOTHESIS | RADIOLOGY AND NUCLEAR MEDICINE | COMPARATIVE EVALUATIONS | HEPARIN
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 11/2019
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 8, pp. 828 - 834
Abstract Objectives This study sought to investigate the characteristics of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation for...
Cardiovascular | femoropopliteal lesion | in-stent restenosis | drug-eluting stent(s) | NITINOL STENT | ZILVER PTX | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTORS | SUPERFICIAL FEMORAL-ARTERY | PROXIMAL POPLITEAL | OUTCOMES | Recurrence | Prospective Studies | Constriction, Pathologic | Humans | Male | Endovascular Procedures - instrumentation | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Female | Ischemia - diagnostic imaging | Drug-Eluting Stents | Endovascular Procedures - adverse effects | Femoral Artery - physiopathology | Japan | Risk Factors | Ischemia - therapy | Treatment Outcome | Ischemia - physiopathology | Popliteal Artery - diagnostic imaging | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Retreatment | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnostic imaging | Aged | Vascular Patency
Cardiovascular | femoropopliteal lesion | in-stent restenosis | drug-eluting stent(s) | NITINOL STENT | ZILVER PTX | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTORS | SUPERFICIAL FEMORAL-ARTERY | PROXIMAL POPLITEAL | OUTCOMES | Recurrence | Prospective Studies | Constriction, Pathologic | Humans | Male | Endovascular Procedures - instrumentation | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Female | Ischemia - diagnostic imaging | Drug-Eluting Stents | Endovascular Procedures - adverse effects | Femoral Artery - physiopathology | Japan | Risk Factors | Ischemia - therapy | Treatment Outcome | Ischemia - physiopathology | Popliteal Artery - diagnostic imaging | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Retreatment | Femoral Artery - diagnostic imaging | Peripheral Arterial Disease - diagnostic imaging | Aged | Vascular Patency
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 05/2018, Volume 11, Issue 10, pp. 957 - 966
The aim of this study was to assess the performance of the fluoropolymer-based paclitaxel-eluting stent (PES) in long femoropopliteal lesions. The...
paclitaxel | peripheral arterial disease | paclitaxel-eluting stent(s) | Eluvia | long femoropopliteal lesions | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | ISCHEMIA | COATED BALLOONS | TRIAL | 1ST-LINE TREATMENT STRATEGIES | NITINOL STENT | TASC C | THERAPY | IMPLANTATION | ARTERY-DISEASE
paclitaxel | peripheral arterial disease | paclitaxel-eluting stent(s) | Eluvia | long femoropopliteal lesions | drug-eluting stent(s) | CARDIAC & CARDIOVASCULAR SYSTEMS | ISCHEMIA | COATED BALLOONS | TRIAL | 1ST-LINE TREATMENT STRATEGIES | NITINOL STENT | TASC C | THERAPY | IMPLANTATION | ARTERY-DISEASE
Journal Article
Journal of Endovascular Therapy, ISSN 1526-6028, 10/2011, Volume 18, Issue 5, pp. 613 - 623
Purpose To report a prospective, single-arm, multicenter clinical study evaluating the Zilver PTX drug-eluting stent for treating the above-the-knee...
Restenosis | Superficial femoral artery | In-stent stenosis | Drug-eluting stent | Peripheral vascular disease | Stenosis | Popliteal artery | Paclitaxel-eluting stent | SURGERY | restenosis | drug-eluting stent | paclitaxel-eluting stent | FEMOROPOPLITEAL ARTERIES | PERFORMANCE | in-stent stenosis | SIROLIMUS-ELUTING STENT | stenosis | popliteal artery | peripheral vascular disease | CORONARY-ARTERIES | TRIAL | IN-VITRO | INHIBITION | IMPLANTATION | superficial femoral artery | BALLOON ANGIOPLASTY | Recurrence | Prospective Studies | Arterial Occlusive Diseases - diagnosis | Constriction, Pathologic | Humans | Middle Aged | Male | Prosthesis Design | Recovery of Function | Endovascular Procedures - instrumentation | Time Factors | Popliteal Artery - physiopathology | Female | Arterial Occlusive Diseases - physiopathology | Paclitaxel - administration & dosage | Republic of Korea | Severity of Illness Index | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Endovascular Procedures - adverse effects | Europe | Femoral Artery - physiopathology | Alloys | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Aged | Arterial Occlusive Diseases - therapy | Vascular Patency | Studies | Design | Medical imaging | Angioplasty | Mortality | Clinical trials | Data collection | Clinical medicine | Stents | Veins & arteries | Cell adhesion & migration
Restenosis | Superficial femoral artery | In-stent stenosis | Drug-eluting stent | Peripheral vascular disease | Stenosis | Popliteal artery | Paclitaxel-eluting stent | SURGERY | restenosis | drug-eluting stent | paclitaxel-eluting stent | FEMOROPOPLITEAL ARTERIES | PERFORMANCE | in-stent stenosis | SIROLIMUS-ELUTING STENT | stenosis | popliteal artery | peripheral vascular disease | CORONARY-ARTERIES | TRIAL | IN-VITRO | INHIBITION | IMPLANTATION | superficial femoral artery | BALLOON ANGIOPLASTY | Recurrence | Prospective Studies | Arterial Occlusive Diseases - diagnosis | Constriction, Pathologic | Humans | Middle Aged | Male | Prosthesis Design | Recovery of Function | Endovascular Procedures - instrumentation | Time Factors | Popliteal Artery - physiopathology | Female | Arterial Occlusive Diseases - physiopathology | Paclitaxel - administration & dosage | Republic of Korea | Severity of Illness Index | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Endovascular Procedures - adverse effects | Europe | Femoral Artery - physiopathology | Alloys | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Aged | Arterial Occlusive Diseases - therapy | Vascular Patency | Studies | Design | Medical imaging | Angioplasty | Mortality | Clinical trials | Data collection | Clinical medicine | Stents | Veins & arteries | Cell adhesion & migration
Journal Article
14.
Full Text
Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions
Journal of Endovascular Therapy, ISSN 1526-6028, 6/2014, Volume 21, Issue 3, pp. 359 - 368
Purpose To compare the performance of drug-coated balloons (DCB) and drug-eluting stents (DES) in long femoropopliteal lesions. Methods A retrospective dual...
Drug-coated balloon | Occlusion | Restenosis | Superficial femoral artery | Drug-eluting balloon | Provisional stenting | Drug-eluting stent | Paclitaxel | Peripheral artery disease | Stenosis | Popliteal artery | Femoropopliteal segment | SURGERY | paclitaxel | restenosis | MULTICENTER | peripheral artery disease | drug-eluting stent | BYPASS | drug-eluting balloon | BARE-METAL STENTS | drug-coated balloon | SINGLE-ARM | stenosis | popliteal artery | NITINOL STENT | TASC C | occlusion | superficial femoral artery | SUPERFICIAL FEMORAL-ARTERY | SUBINTIMAL ANGIOPLASTY | femoropopliteal segment | PERIPHERAL VASCULAR DISEASE | provisional stenting | Recurrence | Constriction, Pathologic | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Female | Retrospective Studies | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Femoral Artery - physiopathology | Kaplan-Meier Estimate | Treatment Outcome | Coated Materials, Biocompatible | Angioplasty, Balloon - instrumentation | Peripheral Arterial Disease - therapy | Disease-Free Survival | Peripheral Arterial Disease - physiopathology | Peripheral Arterial Disease - diagnosis | Blood Flow Velocity | Vascular Access Devices | Aged | Germany | Vascular Patency | Angioplasty | Bias | Bailouts | Drug therapy | Stents | Drug dosages | Patients | Age
Drug-coated balloon | Occlusion | Restenosis | Superficial femoral artery | Drug-eluting balloon | Provisional stenting | Drug-eluting stent | Paclitaxel | Peripheral artery disease | Stenosis | Popliteal artery | Femoropopliteal segment | SURGERY | paclitaxel | restenosis | MULTICENTER | peripheral artery disease | drug-eluting stent | BYPASS | drug-eluting balloon | BARE-METAL STENTS | drug-coated balloon | SINGLE-ARM | stenosis | popliteal artery | NITINOL STENT | TASC C | occlusion | superficial femoral artery | SUPERFICIAL FEMORAL-ARTERY | SUBINTIMAL ANGIOPLASTY | femoropopliteal segment | PERIPHERAL VASCULAR DISEASE | provisional stenting | Recurrence | Constriction, Pathologic | Humans | Middle Aged | Male | Angioplasty, Balloon - adverse effects | Prosthesis Design | Time Factors | Popliteal Artery - physiopathology | Aged, 80 and over | Female | Retrospective Studies | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Femoral Artery - physiopathology | Kaplan-Meier Estimate | Treatment Outcome | Coated Materials, Biocompatible | Angioplasty, Balloon - instrumentation | Peripheral Arterial Disease - therapy | Disease-Free Survival | Peripheral Arterial Disease - physiopathology | Peripheral Arterial Disease - diagnosis | Blood Flow Velocity | Vascular Access Devices | Aged | Germany | Vascular Patency | Angioplasty | Bias | Bailouts | Drug therapy | Stents | Drug dosages | Patients | Age
Journal Article
Jacc-Cardiovascular Interventions, ISSN 1936-8798, 05/2018, Volume 11, Issue 10, pp. 945 - 953
Objectives: The IN.PACT Global Study is the largest prospective, multicenter, independently adjudicated trial to evaluate a paclitaxel drug-coated balloon in...
REVASCULARIZATION | peripheral artery disease | target lesion revascularization | femoropopliteal artery | SFA-LONG | RANDOMIZED-TRIAL | drug-coated balloon | PACLITAXEL | SUPERFICIAL FEMORAL-ARTERY | RESTENOSIS | PERIPHERAL ARTERY-DISEASE | ELUTING BALLOON | angioplasty | REGISTRY | CARDIAC & CARDIOVASCULAR SYSTEMS
REVASCULARIZATION | peripheral artery disease | target lesion revascularization | femoropopliteal artery | SFA-LONG | RANDOMIZED-TRIAL | drug-coated balloon | PACLITAXEL | SUPERFICIAL FEMORAL-ARTERY | RESTENOSIS | PERIPHERAL ARTERY-DISEASE | ELUTING BALLOON | angioplasty | REGISTRY | CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2016, Volume 65, Issue 2, pp. 558 - 570.e10
Abstract Objective Peripheral arterial disease (PAD) is a highly prevalent condition that contributes significantly to the morbidity and mortality of affected...
Surgery | SURGERY | LOCAL-DRUG DELIVERY | INHIBITION | COSTS | FEMOROPOPLITEAL ARTERIAL-DISEASE | ATHEROTHROMBOSIS | UNCOATED BALLOON | ELUTING BALLOONS | RESTENOSIS | RISK | PERIPHERAL VASCULAR DISEASE | MUSCLE-CELL-PROLIFERATION | Cardiovascular Agents - administration & dosage | Limb Salvage | Humans | Risk Factors | Treatment Outcome | Coated Materials, Biocompatible | Angioplasty, Balloon - adverse effects | Angioplasty, Balloon - instrumentation | Equipment Design | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Retreatment | Amputation | Peripheral Arterial Disease - diagnostic imaging | Vascular Access Devices | Odds Ratio | Paclitaxel - administration & dosage | Transluminal angioplasty | Comparative analysis | Health aspects | Mortality | Standards | Paclitaxel | Medical research | Online searching | Medicine, Experimental | Internet/Web search services | Database searching
Surgery | SURGERY | LOCAL-DRUG DELIVERY | INHIBITION | COSTS | FEMOROPOPLITEAL ARTERIAL-DISEASE | ATHEROTHROMBOSIS | UNCOATED BALLOON | ELUTING BALLOONS | RESTENOSIS | RISK | PERIPHERAL VASCULAR DISEASE | MUSCLE-CELL-PROLIFERATION | Cardiovascular Agents - administration & dosage | Limb Salvage | Humans | Risk Factors | Treatment Outcome | Coated Materials, Biocompatible | Angioplasty, Balloon - adverse effects | Angioplasty, Balloon - instrumentation | Equipment Design | Peripheral Arterial Disease - therapy | Peripheral Arterial Disease - physiopathology | Retreatment | Amputation | Peripheral Arterial Disease - diagnostic imaging | Vascular Access Devices | Odds Ratio | Paclitaxel - administration & dosage | Transluminal angioplasty | Comparative analysis | Health aspects | Mortality | Standards | Paclitaxel | Medical research | Online searching | Medicine, Experimental | Internet/Web search services | Database searching
Journal Article